WithoutSideEffectsOralSteroidDepofeminCAS313-06-4forMuscleGrowthName:DEPOFEMIN(Estradiolcypionate)Synonyms:(17b)-estra-1,3,5(10)-triene-3,17-diol17-cyclopentanepropanoate;(17beta)-Estra-1,3,5(10)-triene-3,17-diol17betacyclopentanepropanoate;17beta-Estradiol17-cyclopentylpropionate;17beta-Estradiolcyclopentanepropionate;17beta-Estradiolcypionate;3,5(10)-triene-3,17-diol(17-beta)-estra-17-cyclopentanepropanoate;3,5(10)-triene-3,17-diol(17beta)-estra-17-cyclopentanepropanoate;3-Hydroxyestra-1,3,5(10)-trien-17-yl3-cyclopentylpropanoateCASNumber:313-06-4MolecularFormula:C26H36O3MolecularWeight:396.62EINECS:206-237-8Density:1.15g/cm3BoilingPoint:532.8°Cat760mmHgFlashPoint:207.7°CAppearance:Itiswhiteoroff-whitecrystallinepowderwhichisinsolubleinwater,solubleinchloroform,dioxane,acetone,andslightlysolubleinethanolandvegetableoil.Usage:steroidhormone,pharmaceuticalintermediate.CASDataBaseReference313-06-4(CASDataBaseReference)NISTChemistryReferenceEstradiolcypionate(313-06-4)EPASubstanceRegistrySystemEstra-1,3,5(10)-triene-3,17-diol(17.beta.)-,17-cyclopentanepropanoate(313-06-4)Description:Estradiolcypionate(INN,USAN;Depo-Estradiol,Depofemin,Estradep,manyothers),orestradiolcipionate,isasyntheticester,specificallythe3-cyclopentylpropanoylester,ofthenaturalestrogen,wasfirstintroducedin1952byUpjohnintheUnitedStates,andhasbeeninwidespreadusesince.Estradiolcypionateisabsorbedmoreslowlythanestradiolitself,andforthatreason,itcanbeadministeredlessparedtoothercommonlyusedestradiolesters,viatheintramuscularroute,estradiolcypionatewasfoundtoh***ethelongestdurationofactionwithadurationof~11days,whileestradiolbenzoateandestradiolvaleratewerefoundtolastfor4-5daysand7-8days,respectively.Thismedicationisafemalehormone(estrogen).Itisusedbywomentohelpreducesymptomsofmenopause(suchashotflashes,vaginaldryness).Thesesymptomsarecausedbythebodymakinglessestrogen.Ifyouareusingthismedicationtotreatsymptomsonlyinandaroundthevagina,productsapplieddirectlyinsidethevaginashouldbec***ideredbeforemedicati***thataretakenbymouth,absorbedthroughtheskin,orinjected.Thismedicationmayalsobeusedbywomenwhoarenotabletoproduceenoughestrogen(forexample,duetohypogonadi***,primaryovarianfailure).Applicati***:Depofeminisalong-effectestrogen.ComparedwithEstradiolValerate,ithasstrongerandlongereffects.Itisusedforthetreatmentofovarianinsufficiency,amenorrhea,menopausalsyndrome,senilevaginitis,andprostaticcancer.ThecompoundofDepofeminandMedroxyprogesterone17-acetateisaone-monthlong-termcontraceptiveinjection.skype:edisonxu0907emailtracyatycphardotcom)